- Home
- All Stock List
- NSE
- Ipca Laboratories Ltd Share Price
1,362.50
-5.90 (-0.43%)
-
Outperforms Index
15.33%
Return (1Y)
Beaten Nifty Pharma by 4.17%
-
More Volatile
2.07%
Standard Deviation (1Y)
Higher than Nifty Pharma by 0.99%
-
Consistent Performer
7/12
Months
beaten Nifty Pharma
-
AxisDirect View
No View
1,756
1,052
News & Announcements
-
Ipca Laboratories Ltd soars 1.25%, Gains for third straight session
12 - Jun - 2025 12:00 | 5 days ago
Ipca Laboratories Ltd is up for a third straight session in a row. The stock is quoting at Rs 1406.8, up 1.25% on the day as on 12:49 IST on the NSE. The benchmark NIFTY is down around 0.28% on the day, quoting at 25069.95. The Sensex is at 82276.06, down 0.29%. Ipca Laboratories Ltd has added around 0.19% in last one month.
Meanwhile, Nifty Pharma index of which Ipca Laboratories Ltd is a constituent, has added around 4.05% in last one month and is currently quoting at 22057.15, up 0.76% on the day. The volume in the stock stood at 1.55 lakh shares today, compared to the daily average of 2.94 lakh shares in last one month.
The PE of the stock is 42.27 based on TTM earnings ending March 25.
Powered by Capital Market - Live News
-
Ipca Laboratories consolidated net profit rises 13.81% in the March 2025 quarter
29 - May - 2025 12:00 | 19 days ago
Net profit of Ipca Laboratories rose 13.81% to Rs 67.82 crore in the quarter ended March 2025 as against Rs 59.59 crore during the previous quarter ended March 2024. Sales rose 10.51% to Rs 2246.69 crore in the quarter ended March 2025 as against Rs 2033.03 crore during the previous quarter ended March 2024.
For the full year,net profit rose 34.77% to Rs 737.68 crore in the year ended March 2025 as against Rs 547.35 crore during the previous year ended March 2024. Sales rose 16.02% to Rs 8939.59 crore in the year ended March 2025 as against Rs 7705.04 crore during the previous year ended March 2024.
Particulars Quarter Ended Year Ended Mar. 2025 Mar. 2024 % Var. Mar. 2025 Mar. 2024 % Var. Sales 2246.69 2033.03 11 8939.59 7705.04 16 OPM % 19.09 15.83 - 19.31 17.15 - PBDT 433.17 311.45 39 1734.01 1307.66 33 PBT 333.05 213.32 56 1336.19 950.42 41 NP 67.82 59.59 14 737.68 547.35 35 Powered by Capital Market - Live News
-
Ipca Laboratories announced that the Board of Directors of the Company at its meeting held on 29 May 2025, inter alia, have recommended the final dividend of Rs 2 per equity Share (i.e. 200%) , subject to the approval of the shareholders.
Powered by Capital Market - Live News
-
Ipca Laboratories consolidated net profit rises 13.81% in the March 2025 quarter
29 - May - 2025 12:00 | 19 days ago
Net profit of Ipca Laboratories rose 13.81% to Rs 67.82 crore in the quarter ended March 2025 as against Rs 59.59 crore during the previous quarter ended March 2024. Sales rose 10.51% to Rs 2246.69 crore in the quarter ended March 2025 as against Rs 2033.03 crore during the previous quarter ended March 2024.
For the full year,net profit rose 34.77% to Rs 737.68 crore in the year ended March 2025 as against Rs 547.35 crore during the previous year ended March 2024. Sales rose 16.02% to Rs 8939.59 crore in the year ended March 2025 as against Rs 7705.04 crore during the previous year ended March 2024.
Particulars Quarter Ended Year Ended Mar. 2025 Mar. 2024 % Var. Mar. 2025 Mar. 2024 % Var. Sales 2246.69 2033.03 11 8939.59 7705.04 16 OPM % 19.09 15.83 - 19.31 17.15 - PBDT 433.17 311.45 39 1734.01 1307.66 33 PBT 333.05 213.32 56 1336.19 950.42 41 NP 67.82 59.59 14 737.68 547.35 35 Powered by Capital Market - Live News
-
Ipca Laboratories announced that the Board of Directors of the Company at its meeting held on 29 May 2025, inter alia, have recommended the final dividend of Rs 2 per equity Share (i.e. 200%) , subject to the approval of the shareholders.
Powered by Capital Market - Live News
-
Ipca Laboratories to announce Quarterly Result
33 days ago
-
Ipca Laboratories Ltd soars 1.25%, Gains for third straight session
12 - Jun - 2025 12:00 | 5 days ago
Ipca Laboratories Ltd is up for a third straight session in a row. The stock is quoting at Rs 1406.8, up 1.25% on the day as on 12:49 IST on the NSE. The benchmark NIFTY is down around 0.28% on the day, quoting at 25069.95. The Sensex is at 82276.06, down 0.29%. Ipca Laboratories Ltd has added around 0.19% in last one month.
Meanwhile, Nifty Pharma index of which Ipca Laboratories Ltd is a constituent, has added around 4.05% in last one month and is currently quoting at 22057.15, up 0.76% on the day. The volume in the stock stood at 1.55 lakh shares today, compared to the daily average of 2.94 lakh shares in last one month.
The PE of the stock is 42.27 based on TTM earnings ending March 25.
Powered by Capital Market - Live News
-
Ipca Laboratories consolidated net profit rises 13.81% in the March 2025 quarter
29 - May - 2025 12:00 | 19 days ago
Net profit of Ipca Laboratories rose 13.81% to Rs 67.82 crore in the quarter ended March 2025 as against Rs 59.59 crore during the previous quarter ended March 2024. Sales rose 10.51% to Rs 2246.69 crore in the quarter ended March 2025 as against Rs 2033.03 crore during the previous quarter ended March 2024.
For the full year,net profit rose 34.77% to Rs 737.68 crore in the year ended March 2025 as against Rs 547.35 crore during the previous year ended March 2024. Sales rose 16.02% to Rs 8939.59 crore in the year ended March 2025 as against Rs 7705.04 crore during the previous year ended March 2024.
Particulars Quarter Ended Year Ended Mar. 2025 Mar. 2024 % Var. Mar. 2025 Mar. 2024 % Var. Sales 2246.69 2033.03 11 8939.59 7705.04 16 OPM % 19.09 15.83 - 19.31 17.15 - PBDT 433.17 311.45 39 1734.01 1307.66 33 PBT 333.05 213.32 56 1336.19 950.42 41 NP 67.82 59.59 14 737.68 547.35 35 Powered by Capital Market - Live News
-
Ipca Laboratories announced that the Board of Directors of the Company at its meeting held on 29 May 2025, inter alia, have recommended the final dividend of Rs 2 per equity Share (i.e. 200%) , subject to the approval of the shareholders.
Powered by Capital Market - Live News
-
Ipca Laboratories to announce Quarterly Result
33 days ago
-
Ipca Laboratories Ltd soars 1.25%, Gains for third straight session
12 - Jun - 2025 12:00 | 5 days ago
Ipca Laboratories Ltd is up for a third straight session in a row. The stock is quoting at Rs 1406.8, up 1.25% on the day as on 12:49 IST on the NSE. The benchmark NIFTY is down around 0.28% on the day, quoting at 25069.95. The Sensex is at 82276.06, down 0.29%. Ipca Laboratories Ltd has added around 0.19% in last one month.
Meanwhile, Nifty Pharma index of which Ipca Laboratories Ltd is a constituent, has added around 4.05% in last one month and is currently quoting at 22057.15, up 0.76% on the day. The volume in the stock stood at 1.55 lakh shares today, compared to the daily average of 2.94 lakh shares in last one month.
The PE of the stock is 42.27 based on TTM earnings ending March 25.
Powered by Capital Market - Live News
-
Ipca Laboratories consolidated net profit rises 13.81% in the March 2025 quarter
29 - May - 2025 12:00 | 19 days ago
Net profit of Ipca Laboratories rose 13.81% to Rs 67.82 crore in the quarter ended March 2025 as against Rs 59.59 crore during the previous quarter ended March 2024. Sales rose 10.51% to Rs 2246.69 crore in the quarter ended March 2025 as against Rs 2033.03 crore during the previous quarter ended March 2024.
For the full year,net profit rose 34.77% to Rs 737.68 crore in the year ended March 2025 as against Rs 547.35 crore during the previous year ended March 2024. Sales rose 16.02% to Rs 8939.59 crore in the year ended March 2025 as against Rs 7705.04 crore during the previous year ended March 2024.
Particulars Quarter Ended Year Ended Mar. 2025 Mar. 2024 % Var. Mar. 2025 Mar. 2024 % Var. Sales 2246.69 2033.03 11 8939.59 7705.04 16 OPM % 19.09 15.83 - 19.31 17.15 - PBDT 433.17 311.45 39 1734.01 1307.66 33 PBT 333.05 213.32 56 1336.19 950.42 41 NP 67.82 59.59 14 737.68 547.35 35 Powered by Capital Market - Live News
-
Ipca Laboratories announced that the Board of Directors of the Company at its meeting held on 29 May 2025, inter alia, have recommended the final dividend of Rs 2 per equity Share (i.e. 200%) , subject to the approval of the shareholders.
Powered by Capital Market - Live News
-
Ipca Laboratories consolidated net profit rises 13.81% in the March 2025 quarter
29 - May - 2025 12:00 | 19 days ago
Net profit of Ipca Laboratories rose 13.81% to Rs 67.82 crore in the quarter ended March 2025 as against Rs 59.59 crore during the previous quarter ended March 2024. Sales rose 10.51% to Rs 2246.69 crore in the quarter ended March 2025 as against Rs 2033.03 crore during the previous quarter ended March 2024.
For the full year,net profit rose 34.77% to Rs 737.68 crore in the year ended March 2025 as against Rs 547.35 crore during the previous year ended March 2024. Sales rose 16.02% to Rs 8939.59 crore in the year ended March 2025 as against Rs 7705.04 crore during the previous year ended March 2024.
Particulars Quarter Ended Year Ended Mar. 2025 Mar. 2024 % Var. Mar. 2025 Mar. 2024 % Var. Sales 2246.69 2033.03 11 8939.59 7705.04 16 OPM % 19.09 15.83 - 19.31 17.15 - PBDT 433.17 311.45 39 1734.01 1307.66 33 PBT 333.05 213.32 56 1336.19 950.42 41 NP 67.82 59.59 14 737.68 547.35 35 Powered by Capital Market - Live News
-
Ipca Laboratories announced that the Board of Directors of the Company at its meeting held on 29 May 2025, inter alia, have recommended the final dividend of Rs 2 per equity Share (i.e. 200%) , subject to the approval of the shareholders.
Powered by Capital Market - Live News
-
Ipca Laboratories to announce Quarterly Result
33 days ago
Stock Trivia
Promoter shareholding in Ipca Laboratories Ltd has decreased by -3.41% since past 1 Year
Promoter shareholding in Ipca Laboratories Ltd has decreased by -3.41% since past 1 Year
Promoter shareholding in Ipca Laboratories Ltd has decreased by -3.41% since past 1 Year
Promoter shareholding in Ipca Laboratories Ltd has decreased by -3.41% since past 1 Year
Promoter shareholding in Ipca Laboratories Ltd has decreased by -3.41% since past 1 Year
